CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 94 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,942,156 | +31.1% | 6,780,726 | +98.2% | 0.00% | – |
Q4 2022 | $2,244,836 | -23.5% | 3,420,963 | +0.2% | 0.00% | – |
Q3 2022 | $2,936,000 | +110.8% | 3,413,863 | +34.5% | 0.00% | – |
Q2 2022 | $1,393,000 | -52.0% | 2,537,723 | -3.0% | 0.00% | – |
Q1 2022 | $2,903,000 | -35.5% | 2,615,010 | -0.1% | 0.00% | – |
Q4 2021 | $4,502,000 | -44.6% | 2,617,410 | -1.2% | 0.00% | -100.0% |
Q3 2021 | $8,131,000 | -22.1% | 2,648,610 | -1.0% | 0.00% | 0.0% |
Q2 2021 | $10,432,000 | +37.2% | 2,674,811 | -1.9% | 0.00% | 0.0% |
Q1 2021 | $7,606,000 | -8.6% | 2,726,311 | +0.2% | 0.00% | 0.0% |
Q4 2020 | $8,322,000 | -50.0% | 2,719,711 | -0.6% | 0.00% | -50.0% |
Q3 2020 | $16,639,000 | +2.6% | 2,736,711 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $16,218,000 | +123.0% | 2,744,117 | -0.0% | 0.00% | +100.0% |
Q1 2020 | $7,272,000 | +5.6% | 2,744,130 | +8.4% | 0.00% | 0.0% |
Q4 2019 | $6,885,000 | -79.2% | 2,531,478 | -7.5% | 0.00% | -75.0% |
Q3 2019 | $33,170,000 | +5.8% | 2,736,788 | -0.0% | 0.00% | 0.0% |
Q2 2019 | $31,341,000 | – | 2,737,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 590,000 | $1,605,000 | 1.87% |
MFN Partners Management, LP | 1,487,874 | $4,047,000 | 0.83% |
EcoR1 Capital, LLC | 1,811,000 | $4,926,000 | 0.44% |
Madison Avenue Partners, LP | 132,569 | $361,000 | 0.31% |
Artal Group S.A. | 1,361,584 | $3,703,000 | 0.14% |
TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $539,000 | 0.10% |
Alambic Investment Management, L.P. | 44,266 | $120,000 | 0.10% |
Broderick Brian C | 32,175 | $88,000 | 0.03% |
HORIZON KINETICS ASSET MANAGEMENT LLC | 129,311 | $352,000 | 0.01% |
Sawyer & Company, Inc | 4,100 | $11,000 | 0.01% |